Prasoon Agarwal
Overview
Explore the profile of Prasoon Agarwal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
513
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stopa V, Lileikyte G, Bakochi A, Agarwal P, Beske R, Stammet P, et al.
Intensive Care Med Exp
. 2024 Sep;
12(1):83.
PMID: 39331333
Cardiac arrest is a sudden cessation of heart function, leading to an abrupt loss of blood flow and oxygen to vital organs. This life-threatening emergency requires immediate medical intervention and...
2.
Swati K, Varma S, Parameswari R, Panda S, Agrawal M, Prakash A, et al.
J Biomol Struct Dyn
. 2024 Feb;
:1-19.
PMID: 38305824
In this study, a comprehensive investigation of a set of phytochemicals to identify potential inhibitors for the Forkhead box protein M1 (FOXM1) was conducted. FOXM1 is overexpressed in glioblastoma (GBM)...
3.
Acharjee A, Agarwal P, Gkoutos G
Front Endocrinol (Lausanne)
. 2023 Sep;
14:1266557.
PMID: 37745706
No abstract available.
4.
Agarwal P, Glowacka A, Mahmoud L, Bazzar W, Larsson L, Alzrigat M
Int J Mol Sci
. 2023 May;
24(9).
PMID: 37175848
Amplification of the oncogene is found in ~20% of neuroblastoma (NB) cases and correlates with high-risk disease and poor prognosis. Despite the plethora of studies describing the role of MYCN...
5.
Agarwal P, Wicklow B, Dart A, Hizon N, Sellers E, McGavock J, et al.
Front Endocrinol (Lausanne)
. 2022 Oct;
13:934706.
PMID: 36303872
Objective: Rates of type 2 diabetes (T2D) among adolescents are on the rise. Epigenetic changes could be associated with the metabolic alterations in adolescents with T2D. Methods: We performed a...
6.
Warrier N, Krishnan R, Prabhu V, Hariharapura R, Agarwal P, Kumar P
Int J Mol Sci
. 2022 Jul;
23(14).
PMID: 35886952
Glioblastoma multiforme (GBM) cancer stem cells (GSCs) are one of the strongest contributing factors to treatment resistance in GBM. Identification of biomarkers capable of directly affecting these cells within the...
7.
Tomczyk M, Cheung K, Xiang B, Tamanna N, Fonseca Teixeira A, Agarwal P, et al.
Circ Heart Fail
. 2022 Apr;
15(5):e008547.
PMID: 35418250
Background: High doses of doxorubicin put cancer patients at risk for developing dilated cardiomyopathy. Previously, we showed that doxorubicin treatment decreases SIRT3 (sirtuin 3), the main mitochondrial deacetylase and increases...
8.
Aghanoori M, Agarwal P, Gauvin E, Nagalingam R, Bonomo R, Yathindranath V, et al.
Cell Mol Life Sci
. 2022 Mar;
79(4):193.
PMID: 35298717
Aberrant insulin-like growth factor 1 (IGF-1) signaling has been proposed as a contributing factor to the development of neurodegenerative disorders including diabetic neuropathy, and delivery of exogenous IGF-1 has been...
9.
Acharjee A, Agarwal P, Nash K, Bano S, Rahman T, Gkoutos G
Am J Transl Res
. 2021 Nov;
13(10):11353-11363.
PMID: 34786063
Colon adenocarcinoma (COAD) is a common tumor of the gastrointestinal tract with a high mortality rate. Current research has identified many genes associated with immune infiltration that play a vital...
10.
Warrier N, Agarwal P, Kumar P
Cells
. 2021 Oct;
10(10).
PMID: 34685742
It is imperative to identify the mechanisms that confer stemness to the cancer cells for more effective targeting. Moreover, there are not many studies on the link between stemness characteristics...